EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease

Diabetologia. 2016 Jun;59(6):1121-40. doi: 10.1007/s00125-016-3902-y.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Humans
  • Liraglutide / therapeutic use
  • Liver / drug effects
  • Liver / metabolism
  • Liver / pathology
  • Non-alcoholic Fatty Liver Disease / drug therapy*
  • Non-alcoholic Fatty Liver Disease / metabolism
  • Pioglitazone
  • Risk Factors
  • Thiazolidinediones / therapeutic use

Substances

  • Thiazolidinediones
  • Liraglutide
  • Pioglitazone